Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children - Trial NCT05085717
Access comprehensive clinical trial information for NCT05085717 through Pure Global AI's free database. This phase not specified trial is sponsored by Raincy Montfermeil Hospital Group and is currently Recruiting. The study focuses on HIV Infection. Target enrollment is 960 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Raincy Montfermeil Hospital Group
Timeline & Enrollment
N/A
Mar 17, 2021
Mar 01, 2024
Primary Outcome
evaluation of the proportion of fathers-to-be who fathers who accepted prenatal consultation among
Summary
Insufficient screening and diagnostic delay play a significant role in sustaining the HIV
 epidemic by France.
 
 Gender inequalities major factors reinforce social inequalities in order to of heterosexual
 men born abroad the most later diagnosed with HIV infection. Those gender differences are
 largely due to efficiency antenatal HIV screening, offered to women every pregnancy and
 widely accepted: a billed HIV serology in the context of pregnancy monitoring was found for
 92% pregnant women benefiting from health insurance in 2015 the health of men is not taken
 into account in prenatal follow-up current French. The maternity hospital drains a population
 largely immigrant, often precarious The male prenatal consultation exists but it is not
 organized: it is possible to implement it, provided that the constraints exerted on men are
 taken into account.
 
 the projet study the feasibility and the implementation processes place of prenatal
 consultation of future fathers
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05085717
Non-Device Trial